Alkyl substituted homopiperazine derivatives and their use...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S575000

Reexamination Certificate

active

07923444

ABSTRACT:
This invention relates to novel alkyl substituted homopiperazine derivatives useful as monoamine neurotransmitter re-uptake inhibitors.In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

REFERENCES:
patent: 3247206 (1966-04-01), Yost et al.
patent: 3270004 (1966-08-01), Alter et al.
patent: 6417183 (2002-07-01), Keith et al.
patent: 2003/0109532 (2003-06-01), Sonesson et al.
patent: 2003/0139423 (2003-07-01), Sonesson et al.
patent: 2005/0014740 (2005-01-01), Ruhland et al.
patent: 2006/0084662 (2006-04-01), Ruhland et al.
patent: 0 343 830 (1989-11-01), None
patent: WO-99/32461 (1999-07-01), None
patent: WO-00/40574 (2000-07-01), None
patent: WO-01/46144 (2001-06-01), None
patent: WO-03/029232 (2003-04-01), None
patent: WO-2004/039778 (2004-05-01), None
patent: WO-2005/123707 (2005-12-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Alkyl substituted homopiperazine derivatives and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkyl substituted homopiperazine derivatives and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl substituted homopiperazine derivatives and their use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2703231

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.